Caroline E. Sloan

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness

A. David Paltiel, Kenneth A. Freedberg, Callie A. Scott et al. · Clinical Infectious Diseases · 2009 · 268 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness

Yazdan Yazdanpanah, Caroline E. Sloan, Cécile Charlois-Ou et al. · PLoS ONE · 2010 · 119 citations · Full text

Public Health, Pharmacoeconomics, Population Health Sciences +17

Newer drugs and earlier treatment

Caroline E. Sloan, Karen Champenois, P. Choisy et al. · AIDS · 2011 · 86 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire

Eugène Messou, Marie‐Laure Chaix, Delphine Gabillard et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 80 citations

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Resident Physician Experiences With and Responses to Biased Patients

Shalila S. de Bourmont, Arun Burra, Sarah Nouri et al. · JAMA Network Open · 2020 · 78 citations · Full text

Medicine, Internal Medicine, Medical Education +17